2-(6,7-Dimethoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole

ID: ALA169624

PubChem CID: 44380654

Max Phase: Preclinical

Molecular Formula: C13H16N2O4

Molecular Weight: 264.28

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)OC(C1=NCCN1)CO2

Standard InChI:  InChI=1S/C13H16N2O4/c1-16-8-5-10-11(6-9(8)17-2)19-12(7-18-10)13-14-3-4-15-13/h5-6,12H,3-4,7H2,1-2H3,(H,14,15)

Standard InChI Key:  BNOKWNSPVOHILS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.1292   -1.7917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8500   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5625   -1.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4167   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -1.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1292   -3.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500   -0.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0083   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -2.1417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8500   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208   -1.8042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7250   -3.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4542   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8667   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208   -0.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7250   -4.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  1  1  0
  5  4  1  0
  6  4  2  0
  7  5  1  0
  8  3  2  0
  9  5  2  0
 10  6  1  0
 11 10  2  0
 12  3  1  0
 13  2  1  0
 14 10  1  0
 15 11  1  0
 16  8  1  0
 17 12  1  0
 18 14  1  0
 19 15  1  0
  7 13  1  0
 11  9  1  0
 17 16  1  0
M  END

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 264.28Molecular Weight (Monoisotopic): 264.1110AlogP: 0.85#Rotatable Bonds: 3
Polar Surface Area: 61.31Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.62CX LogP: 0.45CX LogD: -0.76
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.88Np Likeness Score: 0.44

References

1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF..  (1983)  alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants.,  26  (6): [PMID:6133953] [10.1021/jm00360a008]

Source